Whole Chromosome Loss and Associated Breakage-fusion-bridge Cycles Transform Mouse Tetraploid Cells
Overview
Molecular Biology
Affiliations
Whole chromosome gains or losses (aneuploidy) are a hallmark of ~70% of human tumors. Modeling the consequences of aneuploidy has relied on perturbing spindle assembly checkpoint (SAC) components, but interpretations of these experiments are clouded by the multiple functions of these proteins. Here, we used a Cre recombinase-mediated chromosome loss strategy to individually delete mouse chromosomes 9, 10, 12, or 14 in tetraploid immortalized murine embryonic fibroblasts. This methodology also involves the generation of a dicentric chromosome intermediate, which subsequently undergoes a series of breakage-fusion-bridge (BFB) cycles. While the aneuploid cells generally display a growth disadvantage , they grow significantly better in low adherence sphere-forming conditions and three of the four lines are transformed , forming large and invasive tumors in immunocompromised mice. The aneuploid cells display increased chromosomal instability and DNA damage, a mutator phenotype associated with tumorigenesis Thus, these studies demonstrate a causative role for whole chromosome loss and the associated BFB-mediated instability in tumorigenesis and may shed light on the early consequences of aneuploidy in mammalian cells.
Case report: Germline mutation is associated with a giant cell glioblastoma.
Bi Y, Wan D, Chen S, Chen H, Guo L, He X Front Oncol. 2024; 14:1361928.
PMID: 39411129 PMC: 11474180. DOI: 10.3389/fonc.2024.1361928.
Aneuploidy and complex genomic rearrangements in cancer evolution.
Baker T, Waise S, Tarabichi M, Van Loo P Nat Cancer. 2024; 5(2):228-239.
PMID: 38286829 PMC: 7616040. DOI: 10.1038/s43018-023-00711-y.
Modeling specific aneuploidies: from karyotype manipulations to biological insights.
Truong M, Cane-Gasull P, Lens S Chromosome Res. 2023; 31(3):25.
PMID: 37640903 PMC: 10462580. DOI: 10.1007/s10577-023-09735-7.
The KaryoCreate technology generates specific aneuploid karyotypes on demand.
Angrisani A, Fachinetti D Cell Rep Methods. 2023; 3(6):100514.
PMID: 37426746 PMC: 10326432. DOI: 10.1016/j.crmeth.2023.100514.
Whole-Genome Doubling as a source of cancer: how, when, where, and why?.
Sanz-Gomez N, Gonzalez-Alvarez M, De Las Rivas J, de Carcer G Front Cell Dev Biol. 2023; 11:1209136.
PMID: 37342233 PMC: 10277508. DOI: 10.3389/fcell.2023.1209136.